New pain block could cut opioid use after back surgery

NCT ID NCT07370415

First seen Jan 31, 2026 · Last updated Jun 22, 2026 · Updated 22 times

Summary

This study tests two different ultrasound-guided pain blocks for people having lumbar spine surgery. The goal is to see which block reduces the need for opioid painkillers and improves recovery in the first 48 hours after surgery. Eighty adults will be randomly assigned to receive one of the two blocks. The results could help make recovery smoother and safer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PAIN, POSTOPERATIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bursa City Hospital

    Nilufer, Bursa, 16110, Turkey (Türkiye)

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

bupivacaine

What this could lead to

If one block works better, it could mean less pain and less need for strong painkillers after back surgery.

What could go wrong

This is a small, early-stage trial comparing two procedures, so results may not apply to everyone. There is always a small risk of side effects from the block or the anesthetic.

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.